Suppr超能文献

溃疡性结肠炎(UC)中的自身免疫:针对人原肌球蛋白同工型5的主要结肠黏膜B细胞反应。

Autoimmunity in ulcerative colitis (UC): a predominant colonic mucosal B cell response against human tropomyosin isoform 5.

作者信息

Onuma E K, Amenta P S, Ramaswamy K, Lin J J, Das K M

机构信息

Division of Gastroenterology and Hepatology, Department of Medicine, UMDNJ-Robert Wood Johnson Medical School, New Brunswick, NJ 08903, USA.

出版信息

Clin Exp Immunol. 2000 Sep;121(3):466-71. doi: 10.1046/j.1365-2249.2000.01330.x.

Abstract

We set out to examine if the IgG-producing cells in the colonic mucosa in UC are committed to tropomyosin isoform 5 (hTM5), a putative autoantigen in UC. Lamina propria mononuclear cells (LPMC) were isolated from colonoscopic biopsy specimens from recto-sigmoid and proximal colon. Twenty-three patients with UC, eight with Crohn's colitis (CC), and 10 non-inflammatory bowel disease (non-IBD) controls were included. The ELISPOT assays were used to quantify lamina propria B cells producing total immunoglobulin (IgA, IgG, IgM), IgG, IgA, as well as IgG against hTM5 isoform. The median value of percentage of total IgG-producing lymphocytes was similar in UC (12%) and CC (11%), but was significantly (P < 0.0002) higher than non-IBD controls (6%). However, in UC, but not in CC and non-IBD, a large number of lamina propria B cells produced IgG against hTM5 (median values: UC 42%, CC 2.5%, non-IBD 0%). This difference in UC when compared with CC and non-IBD was highly significant (P < 0.00001). Twenty-one of 23 (91%) patients with UC had percentage of anti-hTM5 IgG-producing immunocytes more than 2 s. d. above the mean for non-UC patients. In UC but not in CC and non-IBD controls, the increased number of IgG-producing cells are largely committed to produce IgG against hTM5-related epitope(s).

摘要

我们着手研究溃疡性结肠炎(UC)结肠黏膜中产生免疫球蛋白G(IgG)的细胞是否针对原肌球蛋白异构体5(hTM5),这是UC中一种假定的自身抗原。从直肠乙状结肠和近端结肠的结肠镜活检标本中分离出固有层单核细胞(LPMC)。纳入了23例UC患者、8例克罗恩病(CC)患者和10例非炎症性肠病(非IBD)对照。采用酶联免疫斑点试验(ELISPOT)来定量固有层中产生总免疫球蛋白(IgA、IgG、IgM)、IgG、IgA以及针对hTM5异构体的IgG的B细胞。UC患者(12%)和CC患者(11%)中产生总IgG的淋巴细胞百分比的中位数相似,但显著高于非IBD对照(6%)(P<0.0002)。然而,在UC患者中,而非CC患者和非IBD对照中,大量固有层B细胞产生针对hTM5的IgG(中位数:UC为42%,CC为2.5%,非IBD为0%)。与CC患者和非IBD对照相比,UC患者的这种差异非常显著(P<0.00001)。23例UC患者中有21例(91%)产生抗hTM5 IgG的免疫细胞百分比比非UC患者的平均值高出2个标准差以上。在UC患者中,而非CC患者和非IBD对照中,产生IgG的细胞数量增加主要是针对产生针对hTM5相关表位的IgG。

相似文献

2
Antibody to tropomyosin isoform 5 and complement induce the lysis of colonocytes in ulcerative colitis.
Am J Gastroenterol. 2009 Dec;104(12):2996-3003. doi: 10.1038/ajg.2009.455. Epub 2009 Aug 18.
7
Autoimmunity to tropomyosin isoforms in ulcerative colitis (UC) patients and unaffected relatives.
Clin Exp Immunol. 1998 Aug;113(2):198-205. doi: 10.1046/j.1365-2249.1998.00610.x.
8
Tropomyosins in human diseases: ulcerative colitis.
Adv Exp Med Biol. 2008;644:158-67. doi: 10.1007/978-0-387-85766-4_13.
9
Cellular immune response against tropomyosin isoform 5 in ulcerative colitis.
Clin Immunol. 2001 Dec;101(3):289-95. doi: 10.1006/clim.2001.5133.

引用本文的文献

2
Inflammatory Bowel Diseases: An Updated Overview on the Heat Shock Protein Involvement.
Int J Mol Sci. 2023 Jul 28;24(15):12129. doi: 10.3390/ijms241512129.
4
Cell Intrinsic IL-38 Affects B Cell Differentiation and Antibody Production.
Int J Mol Sci. 2023 Mar 16;24(6):5676. doi: 10.3390/ijms24065676.
5
Human intestinal B cells in inflammatory diseases.
Nat Rev Gastroenterol Hepatol. 2023 Apr;20(4):254-265. doi: 10.1038/s41575-023-00755-6. Epub 2023 Feb 27.
6
Targeting B cells for inflammatory bowel disease treatment: back to the future.
Curr Opin Pharmacol. 2020 Dec;55:90-98. doi: 10.1016/j.coph.2020.10.002. Epub 2020 Nov 6.
7
Autoantibodies as diagnostic markers and potential drivers of inflammation in ulcerative colitis.
PLoS One. 2020 Feb 12;15(2):e0228615. doi: 10.1371/journal.pone.0228615. eCollection 2020.
8
The role of the innate and adaptive immune system in pediatric inflammatory bowel disease.
Inflamm Bowel Dis. 2013 Aug;19(9):2011-20. doi: 10.1097/MIB.0b013e318281f590.
10
Accumulation of tropomyosin isoform 5 at the infection sites of host cells during Cryptosporidium invasion.
Parasitol Res. 2006 Jun;99(1):45-54. doi: 10.1007/s00436-005-0117-4. Epub 2006 Feb 15.

本文引用的文献

2
Externalization of tropomyosin isoform 5 in colon epithelial cells.
Clin Exp Immunol. 1999 Nov;118(2):219-27. doi: 10.1046/j.1365-2249.1999.01046.x.
3
Autoimmunity to tropomyosin isoforms in ulcerative colitis (UC) patients and unaffected relatives.
Clin Exp Immunol. 1998 Aug;113(2):198-205. doi: 10.1046/j.1365-2249.1998.00610.x.
5
Tropomyosin isoforms in nonmuscle cells.
Int Rev Cytol. 1997;170:1-38. doi: 10.1016/s0074-7696(08)61619-8.
6
Broken dogma: penetration of autoantibodies into living cells.
Immunol Today. 1996 Apr;17(4):163-4. doi: 10.1016/s0167-5699(96)90258-3.
9
The role of autoantibodies in autoimmune disease.
Annu Rev Immunol. 1993;11:79-104. doi: 10.1146/annurev.iy.11.040193.000455.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验